98%
921
2 minutes
20
Objective: To analyze the methods used for digestive enzyme measurements in saliva of patients with laryngopharyngeal reflux disease (LPRD) and to investigate their respective diagnostic performances.
Methods: Three independent investigators conducted a PubMED, Scopus, and Cochrane Library database search for studies investigating the digestive saliva enzyme measurements in LPRD patients according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements.
Results: Of the 183 screened studies, 38 studies met the inclusion criteria (1461 females (47.5%) and 1614 males (52.5%)). The mean age of patients was 43.5 years. Two studies assessed the accuracy of salivary pepsin in pediatric populations. Twelve studies included patients with an objective LPRD diagnosis at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing. The lateral flow immunohistochemistry (Peptest) and ELISA were the most common approaches for measuring pepsin. Sensitivity ranged widely (27.0-93.8%) across different methods and thresholds, with Peptest showing 27.0-87.1% sensitivity and 25.0-100% specificity at ≥16 ng/mL threshold. ELISA demonstrated 20.0-93.8% sensitivity and 45.5-84.3% specificity across various cutoff values. Higher thresholds generally improved specificity at the expense of sensitivity. Multiple saliva measurements throughout the 24-hour testing period improved the sensitivity and specificity of the pepsin test. Only three studies considered the measurement of other digestive enzymes, primarily bile salts, as biomarkers of LPRD.
Conclusion: The methods of salivary pepsin collection and measurement substantially influence its diagnostic performance. Future comparative studies are needed to determine the most accurate methodological approach and to establish consensus guidelines for salivary pepsin and other digestive enzyme measurements in LPRD diagnosis through standardized collection, storage, and measurement protocols.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvoice.2025.08.013 | DOI Listing |
J Voice
August 2025
Department of Surgery, Research Institute for Language Science and Technology, University of Mons (UMons), Mons, Belgium; Department of Otolaryngology Head Neck Surgery, CHU Saint-Pierre, Brussels, Belgium; Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, School of Medicine, UFR Simo
Objective: To analyze the methods used for digestive enzyme measurements in saliva of patients with laryngopharyngeal reflux disease (LPRD) and to investigate their respective diagnostic performances.
Methods: Three independent investigators conducted a PubMED, Scopus, and Cochrane Library database search for studies investigating the digestive saliva enzyme measurements in LPRD patients according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements.
Results: Of the 183 screened studies, 38 studies met the inclusion criteria (1461 females (47.
Ann Surg Oncol
August 2025
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Background: Post-esophagectomy reflux remains a significant clinical challenge. This study pioneered the use of salivary pepsin-testing (SPT) as an objective biomarker to explore the reflux, addressing limitations of subjective symptom scoring in esophagectomy outcomes research.
Methods: Consecutive patients (age 18-75 years) with histologically confirmed esophageal carcinoma who underwent esophagectomy were prospectively enrolled to explore the trajectory and associating factors of reflux after surgery.
Laryngoscope
August 2025
LHUB, CHU Saint-Pierre, Brussels, Belgium.
Objective: To evaluate the diagnostic performance of multiple digestive enzyme biomarkers in detecting and characterizing laryngopharyngeal reflux disease (LPRD).
Methods: Patients with LPRD at the 24-h hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing (HEMII-pH) were consecutively recruited from January 2020 to May 2024 from two European hospitals. The control group consisted of adults without symptoms.
Chron Respir Dis
August 2025
Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
ObjectivesGastroesophageal reflux-related chronic cough (GERC), an extraesophageal manifestation of gastroesophageal reflux disease (GERD). Although 24h MII-pH monitoring is the gold standard for diagnosing GERC, its invasiveness, high cost, and limited accessibility hinder widespread use in many clinical settings. This study aimed to develop a non-invasive machine learning model incorporating Peptest™ and GerdQ scores to facilitate GERC detection, particularly in primary care and resource-limited environments where MII-pH testing is not readily available.
View Article and Find Full Text PDFWorld J Otorhinolaryngol Head Neck Surg
June 2025
Otolaryngology, Head and Neck Surgery Department of Fujian Provincial Hospital Provincial Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital Fuzhou Fujian China.
Objective: To investigate the diagnostic value of the fasting hypopharyngeal salivary pepsin concentration test for laryngopharyngeal reflux disease (LPRD).
Methods: Volunteers were grouped by reflux symptom index scale, reflux finding score scale, and 24-h hypopharyngeal-esophageal multichannel intraluminal impedance with pH monitoring results. The study comprised 56, 27, and 20 individuals in the LPRD, asymptomatic laryngopharyngeal reflux (LPR), and asymptomatic non-LPR groups, respectively.